RSS

LIDDS

Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have collaborated to set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm’s development facility in Solna, Sweden. more

Jul 21, 2017 11:24 AM News